May & Baker Nigeria Plc (MAYBAK.ng) Q32019 Interim Report

May & Baker Nigeria Plc (MAYBAK.ng) Q32019 Interim Report

July 12, 2021 nhrithpipweh 0

first_imgMay & Baker Nigeria Plc (MAYBAK.ng) listed on the Nigerian Stock Exchange under the Pharmaceuticals sector has released it’s 2019 interim results for the third quarter.For more information about May & Baker Nigeria Plc (MAYBAK.ng) reports, abridged reports, interim earnings results and earnings presentations, visit the May & Baker Nigeria Plc (MAYBAK.ng) company page on AfricanFinancials.Document: May & Baker Nigeria Plc (MAYBAK.ng)  2019 interim results for the third quarter.Company ProfileMay & Baker Nigeria Plc manufactures and markets a range of pharmaceuticals, vaccines, medical diagnostics, foods and consumer healthcare products in Nigeria. Pharmaceutical products include anti-diabetics, anti-infectives, anti-malaria, analgesics, cough & cold treatments, multivitamins and anxiolytics. May & Bake Nigeria Plc produce a range of Mimee noodles and Lily still water. The company’s head office is in Lagos, Nigeria. May & Baker Nigeria Plc is listed on the Nigerian Stock Exchangelast_img

 

Leave a Reply

Your email address will not be published. Required fields are marked *